Skin and Connective Tissue Diseases

445 trials 165 recruiting

Filter these 445 trials by phase, country and sponsor.

Open in Search →

A Multicentric Randomized Double-Blind Phase 3 Trial Evaluating the Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Active Hidradeni… Recruiting

2023-505818-16-00 Hurley stage 2 active Hidradenitis Suppurativa 5 2025-05-22
T-Guard in dcSSc Recruiting

2024-517283-28-00 diffuse cutaneous systemic sclerosis 9 2025-04-29
Randomized clinical trial to compare oral isotretinoin to standard of care in moderate acne skin of color patients Recruiting

2023-507519-36-00 Acne 5 2025-04-29
Acetic Acid in Cutaneous Ulcers. Randomized Controlled Trial. Recruiting

2023-504348-32-01 Skin ulcer 4 2025-04-27
Botox Treatment for Patients with Hidradenitis Suppurativa: A Within-Person, Randomized, Double-blind, Controlled Study Recruiting

2024-519946-54-00 Hidradenitis Suppurativa 6 2025-04-01
A Phase 3, Multicenter, Open-Label Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of TAK-279 in Subjects with Moderate-t… Recruiting

2024-512496-12-00 Moderate to Severe Plaque Psoriasis 5 2025-04-01
A study to investigate the efficacy and safety of subcutaneous sonelokimab versus placebo and risankizumab (active reference arm) in partici… Recruiting

2024-516219-25-00 psoriatic arthritis 5 2025-03-25
Metal Panel Patch Test Recruiting

2023-507972-35-01 Allergic contact dermatitis 5 2025-03-24
5% KOH solution vs placebo treatment of actinic keratosis with different treatment duration Recruiting

2024-514277-21-00 Actinic keratosis 5 2025-03-19
INtra-tumor miCro dosIng in PatIents with advanced malignant mElanoma receiving aNti-PD1 Therapy. A pilot study. Recruiting

2023-510544-21-00 Malignant Melanoma 3 2025-02-18
A study to test whether spesolimab helps people with a skin condition called pyoderma gangrenosum Recruiting

2024-514306-31-00 Pyoderma gangrenosum 5 2025-02-13
Safety and tolerability of TOP-N53 applied on digital ulcers in patients with systemic sclerosis Recruiting

2024-511861-12-00 Digital ulcers in systemic sclerosis 7 2025-02-04
Phase 2 study evaluating the efficacy of injectable gentamicin in hereditary ichthyosis - GENTIC Recruiting

2023-505570-15-00 Congenital Ichthyosis 4 2025-01-29
IVIG-Spare Trial Recruiting

2024-513681-19-00 Polymyositis 4 2025-01-23
Double-blind placebo-controlled clinical trial (Phase 1b/2a) to evaluate safety and efficacy of IM-250 administration in patients with recur… Recruiting

2024-516368-27-00 Genital herpes infection 9 2025-01-16
EBUL0. A 20-Week Multicentre, Open Study Assessing the Efficacy and Safety of Apremilast in Patients > 6 years of age with Epidermolysis bul… Recruiting

2023-508794-83-00 Epidermolysis bullosa simplex 4 2025-01-10
Role of an hormonal vaginal therapy, the prasterone pessary, in the improvement of the vaginal/vulvar/urinary symptoms in menopausal women w… Recruiting

2023-506211-18-00 Postmenopausal women with previous breast cancer or cu 5 2025-01-09
Safety and efficacy of low-dose interleukin-2 therapy in chronic inflammatory barrier diseases (IL-2-ID) Recruiting

2023-510297-14-00 Primary Sclerosing Cholangitis (PSC) 4 2024-12-27
Phase I/II study to evaluate the efficacy and safety of bacterial collagenase administered in patients with Dupuytren's contracture. Recruiting

2023-507332-20-00 Dupuytren contracture 9 2024-12-18
Safe Stop Trial Melanoma Recruiting

2024-516937-10-01 Melanoma 5 2024-12-18
ACTME Recruiting

2024-516125-31-02 Metastatic Melanoma 9 2024-12-18
[18F]Fluoride PET-CT in psoriasis patients at risk for developing psoriatic arthritis Recruiting

2024-514759-13-01 Psoriasis 4 2024-12-16
A clinical study comparing the efficacy and safety of a new cream containing ivermectin with the efficacy and safety of the originator produ… Recruiting

2023-505897-13-00 Papulopustular Rosacea 5 2024-12-02
MAGE-C2 TCR T cell therapy Recruiting

2024-516922-70-00 advanced melanoma or HNSCC 9 2024-11-29